Featured News

New Phase 2 Clinical Trial: TEV-CeD2 Study

A Promising Step Toward Safer Wheat for Celiac Disease We are proud to share the results of a three-year study funded by the Celiac Disease Foundation, recently published in the…

The ILLUMINATE-101 Study is a phase 2 clinical research study evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.

Halloween is just around the corner, and this year the Celiac Disease Foundation is proud to partner again with our friends at Food Allergy Research & Education (FARE) to promote the Teal Pumpkin Project, which aims to make this holiday safer for everyone affected by celiac disease, food allergies, intolerances, and other conditions.

Many conventional brands actually have a hidden source of gluten in the ingredients list!

What if there was a way to help your immune system become more tolerant of gluten? That’s the potential of VTP-1000, an investigational immunotherapy being studied in the AVALON celiac disease clinical trial.

On May 20 the Disease Foundation hosted its third annual award reception at Digestive Disease Week in Washington, D.C. From prestigious global research prizes to inaugural student and policy leadership awards, the event spotlighted the extraordinary contributions of individuals dedicated to improving the lives of those affected by celiac disease.

The Celiac Disease Foundation is proud to share that for the second year in a row, access to funding for celiac disease research is being made available through the U.S. DOD Congressionally Directed Medical Research Programs (DOD-CDMRP)Peer Review Medical Research Program.

A new study published in the journal Gastro Hep Advances finds that a considerable proportion of Black patients with biopsy-confirmed celiac disease had negative diagnostic blood tests. Traditionally perceived as predominantly affecting non-Hispanic White individuals, this study underscores the importance of bridging existing research gaps to better serve underrepresented populations. 

Using data from the Foundation’s iCureCeliac® Patient Registry, a new observational study helps explain the relationship between persistent celiac disease symptoms, gluten-free diet adherence, mental health, and quality of life.